Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype β1, whereas disopyramide, lignocaine …

V Drvota, B Carlsson, J Häggblad… - Journal of …, 1995 - journals.lww.com
The cardiovascular and electrophysiological effects of amiodarone resemble those of
hypothyroidism. The drug has a structural resemblance to thyroid hormone (T3). Previous …

A physiologically based pharmacokinetic model of amiodarone and its metabolite desethylamiodarone in rats: pooled analysis of published data

JT Lu, Y Cai, F Chen, WW Jia, ZY Hu… - European journal of drug …, 2016 - Springer
Abstract Background and Objective Amiodarone (AMD) is one of the most effective drugs for
rhythm control of atrial fibrillation. The use of AMD is also associated with adverse effects in …

Oral amiodarone: historical overview and development

PT Pollak - … : The Journal of Human Pharmacology and Drug …, 1998 - Wiley Online Library
Objectives. To review the historical development of amiodarone and the changing
perceptions of the drug, and discuss its electrophysiologic, pharmacologic, and …

Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate

IS Hamadeh, TY Langaee, R Dwivedi… - Clinical …, 2014 - Wiley Online Library
Metoprolol is a selective β‐1 adrenergic receptor blocker that undergoes extensive
metabolism by the polymorphic enzyme cytochrome P450 2D6 (CYP2D6). Our objective …

Adherence to amiodarone monitoring recommendations before and after implementation of a centralized pharmacy service: a cohort study

SG Johnson, K Canty, S Billups… - Journal of Pharmacy …, 2010 - journals.sagepub.com
The objective of this study was to determine whether patients enrolled in a centralized
amiodarone monitoring service (AMS) were more adherent to amiodarone surveillance and …

[HTML][HTML] Dataset for amiodarone adverse events compared to placebo using data from randomized controlled trials

MK Moroi, M Ruzieh, NM Aboujamous, M Ghahramani… - Data in brief, 2020 - Elsevier
The dataset presented here provides a detailed description of the adverse events of
amiodarone versus placebo using data from 43 randomized controlled trials. Two authors …

[HTML][HTML] The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice

HL Kim, JB Seo, WY Chung, SH Kim… - The Korean Journal of …, 2014 - ncbi.nlm.nih.gov
Methods Between January 1, 2000 and March 10, 2012, a total of 930 consecutive patients
who had been treated with amiodarone for arrhythmia were reviewed retrospectively. An …

In vitro kinetics of amiodarone and its major metabolite in two human liver cell models after acute and repeated treatments

G Pomponio, CC Savary, C Parmentier, F Bois… - Toxicology in Vitro, 2015 - Elsevier
The limited value of in vitro toxicity data for the in vivo extrapolation has been often attributed
to the lack of kinetic data. Here the in vitro kinetics of amiodarone (AMI) and its mono-N …

Amiodarone and concurrent antiretroviral therapy: a case report and review of the literature

M Naccarato, D Yoong, C la Porte, I Fong - Antiviral Therapy, 2014 - journals.sagepub.com
Therapy for HIV often can make pharmacologic management of comorbidities challenging
since many antiretroviral agents significantly modulate drug metabolism pathways …

Amiodarone: an effective antiarrhythmic drug with unusual side effects

L van Erven, MJ Schalij - Heart, 2010 - heart.bmj.com
Amiodarone was initially developed in the early 1960s as a treatment for angina pectoris,
since it produces coronary vasodilation and decreases cardiac oxygen demand. However …